Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Nu-Med Plus (NUMD) Cash from Financing Activities (2016 - 2025)

Nu-Med Plus' Cash from Financing Activities history spans 10 years, with the latest figure at $30000.0 for Q1 2021.

  • On a quarterly basis, Cash from Financing Activities fell 71.81% to $30000.0 in Q1 2021 year-over-year; TTM through Dec 2021 was $30000.0, a 94.97% decrease, with the full-year FY2025 number at $46267.0, changed N/A from a year prior.
  • Cash from Financing Activities hit $30000.0 in Q1 2021 for Nu-Med Plus, down from $228260.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for NUMD hit a ceiling of $379000.0 in Q1 2017 and a floor of $6132.0 in Q1 2018.
  • Historically, Cash from Financing Activities has averaged $123017.6 across 5 years, with a median of $106439.0 in 2020.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 10844.24% in 2017 and later crashed 98.38% in 2018.
  • Tracing NUMD's Cash from Financing Activities over 5 years: stood at $80910.0 in 2017, then skyrocketed by 76.22% to $142580.0 in 2018, then crashed by 36.94% to $89906.0 in 2019, then skyrocketed by 153.89% to $228260.0 in 2020, then crashed by 86.86% to $30000.0 in 2021.
  • Business Quant data shows Cash from Financing Activities for NUMD at $30000.0 in Q1 2021, $228260.0 in Q4 2020, and $126412.0 in Q3 2020.